awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34385041-86D75CA5-1281-43DB-882A-17EFECD5C2CA
Q34385041-86D75CA5-1281-43DB-882A-17EFECD5C2CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34385041-86D75CA5-1281-43DB-882A-17EFECD5C2CA
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment.
P2860
Q34385041-86D75CA5-1281-43DB-882A-17EFECD5C2CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34385041-86D75CA5-1281-43DB-882A-17EFECD5C2CA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f00e44aa1e11d84511c69e00006c7e0f42360230
P2860
Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies.